We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02308527
Recruitment Status : Active, not recruiting
First Posted : December 4, 2014
Last Update Posted : February 15, 2022
Cancer Research UK
Roche Pharma AG
Imagine for Margo
EUSA Pharma, Inc.
Information provided by (Responsible Party):
University of Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 1, 2021
Estimated Study Completion Date : December 2026